Myomo (MYO) Ending Cash Position : $5.44 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Myomo Ending Cash Position?

Myomo's Ending Cash Position for the quarter that ended in Mar. 2024 was $5.44 Mil.

Myomo's quarterly Ending Cash Position declined from Sep. 2023 ($6.91 Mil) to Dec. 2023 ($6.87 Mil) and declined from Dec. 2023 ($6.87 Mil) to Mar. 2024 ($5.44 Mil).

Myomo's annual Ending Cash Position declined from Dec. 2021 ($15.52 Mil) to Dec. 2022 ($5.35 Mil) but then increased from Dec. 2022 ($5.35 Mil) to Dec. 2023 ($6.87 Mil).

Myomo Ending Cash Position Historical Data

The historical data trend for Myomo's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo Ending Cash Position Chart

Myomo Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

4.54

12.24

15.52

5.35

6.87

Myomo Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															9.26	6.01	6.91	6.87	5.44

Myomo Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Myomo's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5.347	+	1.524
	=	6.87

Myomo's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.872	+	-1.437
	=	5.44

Myomo Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Myomo's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Myomo (MYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (AMEX:MYO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

0M61:Germany 0M61:Germany

Address

137 Portland Street, 4th Floor, Boston, MA, USA, 02114

Website

https://www.myomo.com

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Executives

Thomas F Kirk	director
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Paul R Gudonis	director, officer: Chief Executive Officer	9 HICKORY ROAD, MANCHESTER MA 01944
David A Henry	officer: Chief Financial Officer
Harry Kovelman	officer: Chief Medical Officer	C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Yitzchak Jacobovitz	director	MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Micah Mitchell	officer: Chief Commercial Officer	C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139
Crowley Thomas Aloysius Jr.	director	19 ST CLAIR AV, SPRING LAKE NJ 07762
Cliff Conneighton	officer: Chief Marketing Officer	53 DEPOT ROAD, HOLLS NH 03049
Jonathan Naft	officer: VP, General Manager	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Brandon M Green	officer: Chief Medical Officer	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Ralph A Goldwasser	officer: Chief Financial Officer	BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Davie Mendelsohn	officer: VP, Sales	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Steve Sanghi	director	2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199
Amy K. Knapp	director	75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042